The use of an anti-inflammatory supplement in patients with chronic kidney disease
- PMID: 23828329
- DOI: 10.1515/jcim-2012-0011
The use of an anti-inflammatory supplement in patients with chronic kidney disease
Abstract
Chronic kidney disease (CKD) is characterized by a continuous reduction in kidney function, increased inflammation, and reduced antioxidant capacity. The objective of this study was to assess the effects of a herbal supplement on systemic inflammation and antioxidant status in non-dialysis CKD patients. Sixteen patients with CKD (56.0±16.0 yrs, 171.4±11.9 cm, 99.3±20.2 kg) were randomly chosen to receive a herbal supplement composed of Curcuma longa and Boswellia serrata, or placebo. Plasma levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), glutathione peroxidase (GPx), and serum C-reactive protein (CRP) were measured at baseline and 8 weeks. Baseline data demonstrated elevated inflammation and low antioxidant levels. A significant time effect (p=0.03) and time x compliance interaction effect (p=0.04) were observed for IL-6. No significant differences were observed for any other variables. This study demonstrates that mild and moderate CKD is associated with chronic inflammation and low antioxidant activity. Systemic inflammation and impaired antioxidant status may be greater in CKD populations with multiple comorbidities. Curcumin and Boswellia serrata are safe and tolerable and helped to improve the levels of an inflammatory cytokine.
Similar articles
-
A Pilot Study to Examine the Effects of an Anti-inflammatory Supplement on Eicosanoid Derivatives in Patients with Chronic Kidney Disease.J Altern Complement Med. 2017 Aug;23(8):632-638. doi: 10.1089/acm.2016.0007. Epub 2017 Apr 4. J Altern Complement Med. 2017. PMID: 28375641 Clinical Trial.
-
Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis.Phytomedicine. 2014 May 15;21(6):847-56. doi: 10.1016/j.phymed.2014.02.001. Epub 2014 Mar 22. Phytomedicine. 2014. PMID: 24667331
-
Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.Nutrition. 2015 Mar;31(3):475-9. doi: 10.1016/j.nut.2014.10.001. Epub 2014 Oct 16. Nutrition. 2015. PMID: 25701337 Clinical Trial.
-
Plant food supplements with anti-inflammatory properties: a systematic review (II).Crit Rev Food Sci Nutr. 2013;53(5):507-16. doi: 10.1080/10408398.2012.691916. Crit Rev Food Sci Nutr. 2013. PMID: 23391017 Review.
-
Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review.Complement Ther Med. 2017 Aug;33:32-38. doi: 10.1016/j.ctim.2017.06.002. Epub 2017 Jun 20. Complement Ther Med. 2017. PMID: 28735823 Review.
Cited by 6 articles
-
Curcumin: a modulator of inflammatory signaling pathways in the immune system.Inflammopharmacology. 2019 Oct;27(5):885-900. doi: 10.1007/s10787-019-00607-3. Epub 2019 May 28. Inflammopharmacology. 2019. PMID: 31140036 Review.
-
Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Front Pharmacol. 2018. PMID: 30127736 Free PMC article. Review.
-
Nanoformulations of curcumin: an emerging paradigm for improved remedial application.Oncotarget. 2017 Jul 11;8(39):66680-66698. doi: 10.18632/oncotarget.19164. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029547 Free PMC article. Review.
-
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.Br J Pharmacol. 2017 Jun;174(11):1325-1348. doi: 10.1111/bph.13621. Epub 2016 Oct 21. Br J Pharmacol. 2017. PMID: 27638428 Free PMC article. Review.
-
Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review.Oxid Med Cell Longev. 2016;2016:8598253. doi: 10.1155/2016/8598253. Epub 2016 Aug 3. Oxid Med Cell Longev. 2016. PMID: 27563376 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Research Materials
-
Miscellaneous
